Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467389 · ClinicalTrials.gov registry record · Phase 2
Use of Donepezil for Treatment of Cocaine Dependence
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00467389 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 12 participants.
The verdict
NCT00467389, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of intravenous cocaine in subjects receiving oral donepezil.
Interventions
- OTHER Oral Placebo
- DRUG Donepezil, 5 mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467389
The ClinicalTrials.gov registry entry for NCT00467389 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral Placebo is the first listed.
NCT00467389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467389 about?
NCT00467389 is a clinical study titled "Use of Donepezil for Treatment of Cocaine Dependence". The purpose of this study is to determine the safety of intravenous cocaine in subjects receiving oral donepezil.
What is the current status of trial NCT00467389?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00467389?
The interventions under investigation include: Oral Placebo (OTHER), Donepezil, 5 mg daily (DRUG).
Who is sponsoring clinical trial NCT00467389?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.